Current status and clinical application of patient-derived tumor organoid model in kidney and prostate cancers

키워드

참고문헌 (63)

1. Siegel RL, "Cancer statistics, 2021", CA Cancer J Clin, 71, pp.7~33 (2021)
2. Gao D, "Organoid development in cancer genome discovery", Curr Opin Genet Dev, 30, pp.42~48 (2015)
3. Karantanos T, "Prostate cancer progression after androgen deprivation therapy : mechanisms of castrate resistance and novel therapeutic approaches", Oncogene, 32, pp.5501~5511 (2013)
4. Sobel RE, "Cell lines used in prostate cancer research : a compendium of old and new lines-Part 2", J Urology, 173, pp.360~372 (2005)
5. Namekawa T, "Application of prostate cancer models for preclinical study : advantages and limitations of cell lines, patientderived xenografts, and three-dimensional culture of patientderived cells", Cells, 8, pp.74~ (2019)
6. van Bokhoven A, "Molecular characterization of human prostate carcinoma cell lines", Prostate, 57, pp.205~225 (2003)
7. Chen H, "Urological cancer organoids, patients’ avatars for precision medicine : past, present and future", Cell Biosci, 12, pp.132~ (2022)
8. Jacob F, "A patientderived glioblastoma organoid model and biobank recapitulates inter-and intra-tumoral heterogeneity", Cell, 180, pp.188~204e22 (2020)
9. Kopper O, "An organoid platform for ovarian cancer captures intra-and interpatient heterogeneity", Nat Med, 25, pp.838~849 (2019)
10. Fan H, "Emerging organoid models : leaping forward in cancer research", J Hematol Oncol, 12, pp.142~ (2019)
11. Vela I, "Prostate cancer organoids : a potential new tool for testing drug sensitivity", Expert Rev Anticancer Ther, 15, pp.261~263 (2015)
12. Tuveson D, "Cancer modeling meets human organoid technology", Science, 364, pp.952~955 (2019)
13. Zhou L, "Application of organoid models in prostate cancer research", Front Oncol, 11, pp.736431~ (2021)
14. Usui T, "Establishment of a dog primary prostate cancer organoid using the urine cancer stem cells", Cancer Sci, 108, pp.2383~2392 (2017)
15. Inoue T, "Patient-derived xenografts as in vivo models for research in urological malignancies", Nat Rev Urol, 14, pp.267~283 (2017)
16. Xu R, "Tumor organoid models in precision medicine and investigating cancer-stromal interactions", Pharmacol Ther, 218, pp.107668~ (2021)
17. Gopal S, "Exploiting CRISPR Cas9 in three-dimensional stem cell cultures to model disease", Front Bioeng Biotechnol, 8, pp.692~ (2020)
18. Li Y, "Organoid based personalized medicine : from bench to bedside", Cell Regen, 9, pp.21~ (2020)
19. Botti G, "Organoid biobanks as a new tool for pre-clinical validation of candidate drug efficacy and safety", Int J Physiol Pathophysiol Pharmacol, 13, pp.17~21 (2021)
20. Litwin MS, "The diagnosis and treatment of prostate cancer : a review", JAMA, 317, pp.2532~2542 (2017)
21. Conteduca V, "Clinical features of neuroendocrine prostate cancer", Eur J Cancer, 121, pp.7~18 (2019)
22. Chandrasekar T, "Mechanisms of resistance in castration-resistant prostate cancer(CRPC)", Transl Androl Urol, 4, pp.365~380 (2015)
23. Angeles AK, "Genome-based classification and therapy of prostate cancer", Diagnostics(Basel), 8, pp.62~ (2018)
24. Wyatt AW, "Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer", Genome Biol, 15, pp.426~ (2014)
25. Gao D, "Organoid cultures derived from patients with advanced prostate cancer", Cell, 159, pp.176~187 (2014)
26. Drost J, "Organoid culture systems for prostate epithelial and cancer tissue", Nat Protoc, 11, pp.347~358 (2016)
27. Sato T, "Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche", Nature, 459, pp.262~265 (2009)
28. Karthaus WR, "Identification of multipotent luminal progenitor cells in human prostate organoid cultures", Cell, 159, pp.163~175 (2014)
29. Cook C, "Noggin is required for normal lobe patterning and ductal budding in the mouse prostate", Dev Biol, 312, pp.217~230 (2007)
30. Cheaito K, "Epidermal growth factor is essential for the maintenance of novel prostate epithelial cells isolated from patient-derived organoids", Front Cell Dev Biol, 8, pp.571677~ (2020)
31. Kato M, "Activation of FGF2-FGFR signaling in the castrated mouse prostate stimulates the proliferation of basal epithelial cells", Biol Reprod, 89, pp.81~ (2013)
32. Liu X, "ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells", Am J Pathol, 180, pp.599~607 (2012)
33. Khanna S, "N-acetylcysteine effectively mitigates cadmium-induced oxidative damage and cell death in Leydig cells in vitro", Drug Chem Toxicol, 39, pp.74~80 (2016)
34. Maitland NJ, "Prostate cancer stem cells : do they have a basal or luminal phenotype?", Horm Cancer, 2, pp.47~61 (2011)
35. Wang ZA, "Luminal cells are favored as the cell of origin for prostate cancer", Cell Rep, 8, pp.1339~1346 (2014)
36. Lee JK, "N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells", Cancer Cell, 29, pp.536~547 (2016)
37. Park JW, "Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay", Proc Natl Acad Sci U S A, 113, pp.4482~4487 (2016)
38. Wang X, "A luminal epithelial stem cell that is a cell of origin for prostate cancer", Nature, 461, pp.495~500 (2009)
39. Pappas KJ, "Prostate organoid cultures as tools to translate genotypes and mutational profiles to pharmacological responses", J Vis Exp, pp.e60346~ (2019)
40. Hsieh JJ, "Renal cell carcinoma", Nat Rev Dis Primers, 3, pp.1~19 (2017)
41. Gerlinger M, "Intratumor heterogeneity and branched evolution revealed by multiregion sequencing", N Engl J Med, 366, pp.883~892 (2012)
42. Kuroda N, "Recent classification of renal epithelial tumors", Med Mol Morphol, 47, pp.68~75 (2014)
43. Valente MJ, "A rapid and simple procedure for the establishment of human normal and cancer renal primary cell cultures from surgical specimens", PLoS One, 6, pp.e19337~ (2011)
44. Grassi L, "Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases", Cell Death Dis, 10, pp.201~ (2019)
45. Gedye C, "Cancer stem cells are underestimated by standard experimental methods in clear cell renal cell carcinoma", Sci Rep, 6, pp.25220~ (2016)
46. 나준채, "Establishment of patient-derived three-dimensional organoid culture in renal cell carcinoma", Investigative and Clinical Urology, 61(2), pp.216~223 (2020), 대한비뇨의학회[DOI]
47. Fendler A, "Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients", Nat Commun, 11, pp.929~ (2020)
48. "Establishment of kidney cancer organoid cultures" (2020)[URL]
49. Batchelder CA, "Three dimensional culture of human renal cell carcinoma organoids", PLoS One, 10, pp.e0136758~ (2015)
50. Sun G, "Formation and optimization of three-dimensional organoids generated from urine-derived stem cells for renal function in vitro", Stem Cell Res Ther, 11, pp.309~ (2020)
51. Wang S, "The potential of organoids in urological cancer research", Nat Rev Urol, 14, pp.401~414 (2017)
52. Zhang P, "Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1activation", Nat Med, 23, pp.1055~1062 (2017)
53. Yan Y, "The novel BET-CBP", p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer, 2019, pp.11, e10659~
54. Song H, "Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states", Nat Commun, 13, pp.141~ (2022)
55. McCray T, "Single-cell RNA-Seq analysis identifies a putative epithelial stem cell population in human primary prostate cells in monolayer and organoid culture conditions", Am J Clin Exp Urol, 7, pp.123~138 (2019)
56. Robinson D, "Integrative clinical genomics of advanced prostate cancer", Cell, 161, pp.1215~1228 (2015)
57. Arora VK, "Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade", Cell, 155, pp.1309~1322 (2013)
58. Mu P, "SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer", Science, 355, pp.84~88 (2017)
59. Han H, "Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis", Cell Rep, 39, pp.110595~ (2022)
60. Li Z, "Patient-derived renal cell carcinoma organoids for personalized cancer therapy", Clin Transl Med, 12, pp.e970~ (2022)
61. Bolck HA, "Tracing clonal dynamics reveals that two-and three-dimensional patient-derived cell models capture tumor heterogeneity of clear cell renal cell carcinoma", Eur Urol Focus, 7, pp.152~162 (2021)
62. Kazama A, "Development of patient‑derived tumor organoids and a drug testing model for renal cell carcinoma", Oncol Rep, 46, pp.1~8 (2021)
63. Clevers H, "Modeling development and disease with organoids", Cell, 165, pp.1586~1597 (2016)

관련 논문AI추천